Publications by authors named "Kees Hovingh"

Claim this Profile
R
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate Reduction.
Paul M Ridker, Florian M M Baeres, Anders Hveplund, Mads M D Engelmann, G Kees Hovingh

JAMA Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.
Johannes F E Mann, Nikolaus Marx, John E Deanfield, Scott S Emerson, Silvio E Inzucchi, G Kees Hovingh

Diabetes Care· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial.
John Deanfield, A Michael Lincoff, Steven E Kahn, Scott S Emerson, Ildiko Lingvay, G Kees Hovingh

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: a Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial.
Marianna Fontana, Pablo Garcia-Pavia, Martha Grogan, Sanjiv J Shah, Mads D M Engelmann, G Kees Hovingh

Circulation· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study.
Jordan M Kraaijenhof, Nick S Nurmohamed, Ask T Nordestgaard, Laurens F Reeskamp, Erik S G Stroes, G Kees Hovingh

Eur Heart J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global disparities in access to lipid-lowering therapies for patients with homozygous familial hypercholesterolemia - A physician survey.
Willemijn A M Schonck, Janneke W C M Mulder, Tycho R Tromp, Laurens F Reeskamp, G Kees Hovingh

J Clin Lipidol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma reduction of apolipoprotein C-III with olezarsen leads to significant reductions in postprandial triglyceride levels: Results from a randomized trial.
Jordan M Kraaijenhof, Merel C Peletier, Nick S Nurmohamed, G Kees Hovingh, Veronica J Alexander

Eur J Prev Cardiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
Nikolaus Marx, John E Deanfield, Johannes F E Mann, Rosario Arechavaleta, Stephen C Bain, G Kees Hovingh

Circulation· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iCARE4CVD: an innovative European consortium aiming to improve personalized cardiovascular care.
Hans-Peter Brunner-La Rocca, Dirk Müller-Wieland, G Kees Hovingh

Eur Heart J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.
Darren K McGuire, Nikolaus Marx, Sharon L Mulvagh, John E Deanfield, Silvio E Inzucchi, G Kees Hovingh

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world family planning and pregnancy practices in women with homozygous familial hypercholesterolemia.
Janneke W C M Mulder, Willemijn A M Schonck, Tycho R Tromp, M Doortje Reijman, Laurens F Reeskamp, G Kees Hovingh

Atherosclerosis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era.
Janneke W C M Mulder, M Doortje Reijman, D Meeike Kusters, Eric Boersma, Fahad Alnouri, G Kees Hovingh

J Am Coll Cardiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma proteomics improves prediction of coronary plaque progression.
Jordan M Kraaijenhof, Nick S Nurmohamed, Michiel J Bom, E L Gaillard, Shirin Ibrahim, G Kees Hovingh

Eur Heart J Cardiovasc Imaging· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.
Amany Elshorbagy, Antonio J Vallejo-Vaz, Fotios Barkas, Alexander R M Lyons, Christophe A T Stevens, G Kees Hovingh

Eur Heart J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cumulative LDL cholesterol and other risk factors on coronary artery disease prevalence in patients with familial hypercholesterolaemia.
Shirin Ibrahim, G Kees Hovingh, Barbara A Hutten, Erik S G Stroes, Laurens F Reeskamp

Eur J Prev Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study.
Jordan M Kraaijenhof, Marije J Kerkvliet, Nick S Nurmohamed, Aldo Grefhorst, Jeffrey Kroon, G Kees Hovingh

Eur J Prev Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Coronary Computed Tomography Angiography in the Diagnosis, Risk Stratification, and Management of Patients with Diabetes and Chest Pain.
Willem R van de Vijver, Jasper Hennecken, Ioannis Lagogiannis, Candelas Pérez Del Villar, Cristian Herrera, G Kees Hovingh

Rev Cardiovasc Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia.
Albert Wiegman, Andrea Ruzza, G Kees Hovingh, Raul D Santos, François Mach

Eur J Prev Cardiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia.
Shirin Ibrahim, Merel L Hartgers, Laurens F Reeskamp, Linda Zuurbier, Joep Defesche, G Kees Hovingh

Atherosclerosis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT): Outcomes by Sex.
Subodh Verma, Helen M Colhoun, Dror Dicker, G Kees Hovingh, Steven E Kahn

J Am Coll Cardiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ursodeoxycholic Acid for Trans Intestinal Cholesterol Excretion Stimulation: A Randomized Placebo Controlled Crossover Study.
Reindert F Oostveen, Yannick Kaiser, Merel L Hartgers, Emma C E Meessen, Aldo Grefhorst, G Kees Hovingh

J Am Heart Assoc· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype.
Jordan M Kraaijenhof, Barend M Mol, Nick S Nurmohamed, Kim E Dzobo, Jeffrey Kroon, G Kees Hovingh

Atherosclerosis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 6 plasma levels are associated with progression of coronary plaques.
Jordan M Kraaijenhof, Nick S Nurmohamed, Evangelos Tzolos, Mo Meah, Jolien Geers, G Kees Hovingh

Open Heart· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
John Deanfield, Subodh Verma, Benjamin M Scirica, Steven E Kahn, Scott S Emerson, G Kees Hovingh

Lancet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic Background Modifies Risk of Coronary Artery Disease Among Individuals With Heterozygous Familial Hypercholesterolemia.
Laurens F Reeskamp, Injeong Shim, Jacqueline S Dron, Shirin Ibrahim, Tycho R Tromp, G Kees Hovingh

JACC Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis